PREVAIL THERAPEUTICS Trademark

Trademark Overview

On Friday, August 3, 2018, a trademark application was filed for PREVAIL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PREVAIL THERAPEUTICS trademark a serial number of 88064247. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Prevail Therapeutics, Inc.. The PREVAIL THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurodegenerative diseases and lysosomal disorders; none of the foregoing for use in treating incontinence
prevail therapeutics

General Information

Serial Number88064247
Word MarkPREVAIL THERAPEUTICS
Filing DateFriday, August 3, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6200943
Registration DateTuesday, November 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 29, 2019

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations for the treatment of neurodegenerative diseases and lysosomal disorders; none of the foregoing for use in treating incontinence

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 9, 2018
Primary Code005
First Use Anywhere DateWednesday, September 2, 2020
First Use In Commerce DateWednesday, September 2, 2020

Trademark Owner History

Party NamePrevail Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NamePrevail Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NamePrevail Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, March 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, October 13, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, October 10, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 28, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 9, 2020USE AMENDMENT FILED
Thursday, September 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 9, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, March 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 19, 2020EXTENSION 2 GRANTED
Thursday, March 19, 2020EXTENSION 2 FILED
Thursday, March 19, 2020TEAS EXTENSION RECEIVED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2019EXTENSION 1 GRANTED
Wednesday, September 25, 2019EXTENSION 1 FILED
Wednesday, September 25, 2019TEAS EXTENSION RECEIVED
Monday, April 8, 2019ASSIGNED TO EXAMINER
Tuesday, March 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 21, 2018ASSIGNED TO LIE
Friday, November 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 30, 2018EXAMINER'S AMENDMENT ENTERED
Friday, November 30, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 30, 2018EXAMINERS AMENDMENT E-MAILED
Friday, November 30, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 21, 2018ASSIGNED TO EXAMINER
Thursday, August 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 7, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics prevail none foregoing treating incontinence disorders lysosomal preparations treatment neurodegenerative diseases